Search research articles
Contact Us
Filters
Showing results (191-200 of 313) with videos related to
Page
of 32
Sort By:
Lancet Regional Health. Americas
|
July 21, 2025
Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
Guilherme Diogo Silva, Leonardo Zumerkorn Pipek, Mateus Boaventura de Oliveira, et al.
Arquivos De Neuro-Psiquiatria
|
October 5, 2002
[The BCTRIMS expanded consensus on treatment of multiple sclerosis: II. The evidences for the use of glucocorticoids and immunomodulatory treatments]
Marcos Aurélio Moreira, Marco Aurélio Lana-Peixoto, Dagoberto Callegaro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 20, 2020
Improvements in muscle strength, power, and size and self-reported fatigue as mediators of the effect of resistance exercise on physical performance breast cancer survivor women: a randomized controlled trial
Samarita Beraldo Santagnello, Fernanda Maria Martins, Gersiel Nascimento de Oliveira Junior, et al.
Age (Dordrecht, Netherlands)
|
March 18, 2016
Effect of resistance training on muscular strength and indicators of abdominal adiposity, metabolic risk, and inflammation in postmenopausal women: controlled and randomized clinical trial of efficacy of training volume
Paulo Ricardo Prado Nunes, Larissa Corrêa Barcelos, Anselmo Alves Oliveira, et al.
Orphanet Journal of Rare Diseases
|
August 12, 2025
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase beta
Ian Keyzor, Ana Maria Martins, Sema Kalkan Uçar, et al.
European Journal of Pediatrics
|
July 10, 2012
Revised recommendations for the management of Gaucher disease in children
Paige Kaplan, Hagit Baris, Linda De Meirleir, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 2, 2010
Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry
Torquil Watt, Alessandro P Burlina, Chiara Cazzorla, et al.
International Immunopharmacology
|
September 4, 2012
Role of interplay between IL-4 and IFN-γ in the in regulating M1 macrophage polarization induced by Nattectin
Edson Kiyotaka Ishizuka, Marcio José Ferreira, Lidiane Zito Grund, et al.
Biological & Pharmaceutical Bulletin
|
September 9, 2010
The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice
Karine Maria Martins Bezerra Carvalho, Talita Cavalcante Morais, Tiago Sousa de Melo, et al.
Orphanet Journal of Rare Diseases
|
November 27, 2024
α-mannosidosis diagnosis in Brazilian patients with MPS-like symptoms
Maryana Marins, Marco Antonio Curiati, Caio Perez Gomes, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 313) with videos related to
Sort By:
Page
of 32
Lancet Regional Health. Americas
|
July 21, 2025
Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
Guilherme Diogo Silva, Leonardo Zumerkorn Pipek, Mateus Boaventura de Oliveira, et al.
Arquivos De Neuro-Psiquiatria
|
October 5, 2002
[The BCTRIMS expanded consensus on treatment of multiple sclerosis: II. The evidences for the use of glucocorticoids and immunomodulatory treatments]
Marcos Aurélio Moreira, Marco Aurélio Lana-Peixoto, Dagoberto Callegaro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 20, 2020
Improvements in muscle strength, power, and size and self-reported fatigue as mediators of the effect of resistance exercise on physical performance breast cancer survivor women: a randomized controlled trial
Samarita Beraldo Santagnello, Fernanda Maria Martins, Gersiel Nascimento de Oliveira Junior, et al.
Age (Dordrecht, Netherlands)
|
March 18, 2016
Effect of resistance training on muscular strength and indicators of abdominal adiposity, metabolic risk, and inflammation in postmenopausal women: controlled and randomized clinical trial of efficacy of training volume
Paulo Ricardo Prado Nunes, Larissa Corrêa Barcelos, Anselmo Alves Oliveira, et al.
Orphanet Journal of Rare Diseases
|
August 12, 2025
A multi-country time and motion study to describe the experience and burden associated with the treatment of Fabry disease with enzyme replacement therapy with agalsidase alfa and agalsidase beta
Ian Keyzor, Ana Maria Martins, Sema Kalkan Uçar, et al.
European Journal of Pediatrics
|
July 10, 2012
Revised recommendations for the management of Gaucher disease in children
Paige Kaplan, Hagit Baris, Linda De Meirleir, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
October 2, 2010
Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry
Torquil Watt, Alessandro P Burlina, Chiara Cazzorla, et al.
International Immunopharmacology
|
September 4, 2012
Role of interplay between IL-4 and IFN-γ in the in regulating M1 macrophage polarization induced by Nattectin
Edson Kiyotaka Ishizuka, Marcio José Ferreira, Lidiane Zito Grund, et al.
Biological & Pharmaceutical Bulletin
|
September 9, 2010
The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice
Karine Maria Martins Bezerra Carvalho, Talita Cavalcante Morais, Tiago Sousa de Melo, et al.
Orphanet Journal of Rare Diseases
|
November 27, 2024
α-mannosidosis diagnosis in Brazilian patients with MPS-like symptoms
Maryana Marins, Marco Antonio Curiati, Caio Perez Gomes, et al.
Page
of 32